You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
{{ message }}
This repository has been archived by the owner on Nov 19, 2024. It is now read-only.
I forget how this information comes from FRDB - but one might be able to supplement it with FDA SPL data.
Primary
Substance halts or slows disease progression. Treatment often targets the primary pathology of a disease.
Preventing
Substance is intended to prevent the development of a medical condition.
Palliative
Substance improves the quality of life by alleviating the associated symptoms, without necessarily affecting the underlying pathology.
Secondary
Substance treats adverse effects associated with the treatment of a condition.
Diagnostic
A substance used for diagnostic purposes, including disease detection and monitoring of disease progression.
Inactive Ingredient
An ingredient of a given formulation (most frequently, an excipient) that does not exhibit pharmacological activity. In this case, a condition is only related to such compound via the formulation used to affect (treat or diagnose) this condition.
The text was updated successfully, but these errors were encountered:
Sign up for freeto subscribe to this conversation on GitHub.
Already have an account?
Sign in.
FDA's SPL contains information on the intended use of products that corresponds nicely to Treament Modality in Inxight.
https://www.fda.gov/industry/structured-product-labeling-resources/intent-use
I forget how this information comes from FRDB - but one might be able to supplement it with FDA SPL data.
Primary
Substance halts or slows disease progression. Treatment often targets the primary pathology of a disease.
Preventing
Substance is intended to prevent the development of a medical condition.
Palliative
Substance improves the quality of life by alleviating the associated symptoms, without necessarily affecting the underlying pathology.
Secondary
Substance treats adverse effects associated with the treatment of a condition.
Diagnostic
A substance used for diagnostic purposes, including disease detection and monitoring of disease progression.
Inactive Ingredient
An ingredient of a given formulation (most frequently, an excipient) that does not exhibit pharmacological activity. In this case, a condition is only related to such compound via the formulation used to affect (treat or diagnose) this condition.
The text was updated successfully, but these errors were encountered: